1. De Serres G, Markowski F, Toth E, Landry M, Auger D, Mercier M, Bélanger P, Turmel B, Arruda H, Boulianne N, Ward BJ, Skowronski DM. Largest measles epidemic in North America in a decade–Quebec, Canada, 2011: contribution of susceptibility, serendipity, and superspreading events. J Infect Dis. 2013; 207:990–998.
Article
2. Kline SE, Hedemark LL, Davies SF. Outbreak of tuberculosis among regular patrons of a neighborhood bar. N Engl J Med. 1995; 333:222–227.
Article
3. Althaus CL. Ebola superspreading. Lancet Infect Dis. 2015; 15:507–508.
Article
4. Li Y, Yu IT, Xu P, Lee JH, Wong TW, Ooi PL, Sleigh AC. Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore. Am J Epidemiol. 2004; 160:719–728.
Article
5. Centers for Disease Control and Prevention (CDC). Severe acute respiratory syndrome-Singapore, 2003. MMWR Morb Mortal Wkly Rep. 2003; 52:405–411.
6. Shen Z, Ning F, Zhou W, He X, Lin C, Chin DP, Zhu Z, Schuchat A. Superspreading SARS events, Beijing, 2003. Emerg Infect Dis. 2004; 10:256–260.
Article
7. Lloyd-Smith JO, Schreiber SJ, Kopp PE, Getz WM. Super-spreading and the effect of individual variation on disease emergence. Nature. 2005; 438:355–359.
Article
8. James A, Pitchford JW, Plank MJ. An event-based model of superspreading in epidemics. Proc Biol Sci. 2007; 274:741–747.
Article
9. Stein RA. Superspreaders in infectious diseases. Int J Infect Dis. 2011; 15:e510–e513.
10. Park SH, Kim WJ, Yoo JH, Choi JH. Epidemiologic parameters of the Middle East Respiratory Syndrome outbreak in Korea, 2015. Infect Chemother. 2016; 48:108–117.
Article
11. Galvani AP, May RM. Epidemiology: dimensions of superspreading. Nature. 2005; 438:293–295.